| 000 | 01777 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513230358.0 | ||
| 264 | 0 | _c20010322 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem.86.2.7179 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaoletti, A M | |
| 245 | 0 | 0 |
_aEvidence that cyproterone acetate improves psychological symptoms and enhances the activity of the dopaminergic system in postmenopause. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cFeb 2001 |
||
| 300 |
_a608-12 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAnxiety |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCyproterone Acetate _xtherapeutic use |
| 650 | 0 | 4 | _aDepression |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMental Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostmenopause _xphysiology |
| 650 | 0 | 4 |
_aPremenopause _xphysiology |
| 650 | 0 | 4 |
_aProlactin _xblood |
| 650 | 0 | 4 | _aPsychological Tests |
| 650 | 0 | 4 | _aPsychometrics |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSulpiride |
| 700 | 1 | _aFloris, S | |
| 700 | 1 | _aMannias, M | |
| 700 | 1 | _aOrrù, M | |
| 700 | 1 | _aCrippa, D | |
| 700 | 1 | _aOrlandi, R | |
| 700 | 1 | _aDel Zompo M, M | |
| 700 | 1 | _aMelis, G B | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 86 _gno. 2 _gp. 608-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.86.2.7179 _zAvailable from publisher's website |
| 999 |
_c11097603 _d11097603 |
||